Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Raytel and St Jude develop ICD (implantable cardioverter defibrillators) monitoring system:

This article was originally published in Clinica

Executive Summary

Raytel Medical and St Jude Medical are to complete the development of Housecall, a dedicated transtelephonic system for monitoring St Jude's Ventritex implantable cardioverter defibrillators (ICDs). Raytel, of San Mateo, California, already has a monitoring system for 81,000 pacemaker patients in the US. The new system will enable technicians to transmit stored and real-time information on cardiac activity and ICD performance. The results are interpreted and a report transferred to the physician for evaluation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT082528

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel